Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
Pressure BioSciences Inc. (PBIO) had Consolidated Net Income/Loss of $-7.12M for the most recently reported fiscal quarter, ending 2024-06-30.
| Income Statement Financials | |
$0.42M |
|
$-7.75M |
|
$0.38M |
|
$0.04M |
|
$2.35M |
|
$-1.93M |
|
$-5.19M |
|
$-7.12M |
|
$-7.12M |
|
$-7.12M |
|
$-7.12M |
|
|
Consolidated Net Income/Loss |
$-7.12M |
$-7.12M |
|
$-1.93M |
|
$-1.13M |
|
51.41M |
|
51.41M |
|
$-0.15 |
|
$-0.15 |
|
| Balance Sheet Financials | |
$0.87M |
|
$0.07M |
|
$6.01M |
|
$6.88M |
|
$43.58M |
|
$0.16M |
|
$0.53M |
|
$44.11M |
|
$-37.23M |
|
$-42.52M |
|
$-37.23M |
|
54.04M |
|
| Cash Flow Statement Financials | |
$-2.57M |
|
-- |
|
$2.50M |
|
$0.08M |
|
$0.01M |
|
$-0.07M |
|
$0.39M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.02 |
|
-- |
|
-- |
|
-0.00 |
|
-0.77 |
|
10.49% |
|
-457.23% |
|
-457.23% |
|
-- |
|
-1687.20% |
|
-1837.05% |
|
$-2.57M |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
0.70 |
|
2.29 |
|
39.26 |
|
19.12% |
|
16.74% |
|
-103.45% |
|
19.20% |
|
$-0.69 |
|
$-0.05 |
|
$-0.05 |
|